Source: Cullen Browder, WRAL, 10/13/20

Thousands of North Carolina residents have stepped up to help test the safety and effectiveness of potential coronavirus vaccines, but the trials need even more participants. Pfizer and Moderna are among nine companies in Phase III clinical trials with the vaccine candidates, and both are working in North Carolina. "The goal of 30,000 [participants] for the Pfizer trial had been reached, but they continue to enroll more," said Dr. Wayne Harper, a primary investigator for Raleigh-based Wake Research, which is conducting some of the vaccine trials.

For more of this story, click here.